Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles van Cutsem

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2007
Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected AfricansMolebogeng X Rangaka, Lavanya Diwakar, Ronnett Seldon, et al.
American Journal of Respiratory and Critical Care Medicine|December 13, 2006
Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infectionMolebogeng Xheeda Rangaka, Katalin A Wilkinson, Ronnett Seldon, et al.
AIDS (London, England)|August 5, 2010
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007Morna Cornell, Anna Grimsrud, Lara Fairall, et al.
Plos One|November 12, 2015
Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment SuccessJohnny Flippie Daniels, Mohammed Khogali, Erika Mohr, et al.
AIDS (London, England)|June 19, 2018
The impact of lay counselors on HIV testing rates: quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South AfricaJanice Hu, Pascal Geldsetzer, Sarah Jane Steele, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 16, 2010
Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaborationMorna Cornell, Karl Technau, Lara Fairall, et al.
Plos One|March 13, 2019
Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional surveyBella Hwang, Amir Shroufi, Tinne Gils, et al.
Clinical and Vaccine Immunology : CVI|May 25, 2007
Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vectorTom G Connell, Muki S Shey, Ronnett Seldon, et al.
American Journal of Respiratory and Critical Care Medicine|August 30, 2008
Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndromeGraeme Meintjes, Katalin Andrea Wilkinson, Molebogeng Xheeda Rangaka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2010
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern AfricaLukas Fenner, Martin W G Brinkhof, Olivia Keiser, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2007
Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected AfricansMolebogeng X Rangaka, Lavanya Diwakar, Ronnett Seldon, et al.
American Journal of Respiratory and Critical Care Medicine|December 13, 2006
Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infectionMolebogeng Xheeda Rangaka, Katalin A Wilkinson, Ronnett Seldon, et al.
AIDS (London, England)|August 5, 2010
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007Morna Cornell, Anna Grimsrud, Lara Fairall, et al.
Plos One|November 12, 2015
Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment SuccessJohnny Flippie Daniels, Mohammed Khogali, Erika Mohr, et al.
AIDS (London, England)|June 19, 2018
The impact of lay counselors on HIV testing rates: quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South AfricaJanice Hu, Pascal Geldsetzer, Sarah Jane Steele, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 16, 2010
Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaborationMorna Cornell, Karl Technau, Lara Fairall, et al.
Plos One|March 13, 2019
Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional surveyBella Hwang, Amir Shroufi, Tinne Gils, et al.
Clinical and Vaccine Immunology : CVI|May 25, 2007
Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vectorTom G Connell, Muki S Shey, Ronnett Seldon, et al.
American Journal of Respiratory and Critical Care Medicine|August 30, 2008
Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndromeGraeme Meintjes, Katalin Andrea Wilkinson, Molebogeng Xheeda Rangaka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2010
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern AfricaLukas Fenner, Martin W G Brinkhof, Olivia Keiser, et al.
Pageof 8